T1	PROC 44 76	Estudio para valorar la eficacia
T2	ANAT 101 114	células madre
#1	AnnotatorNotes T2	C0038250; Stem cells; Cell
T3	DISO 152 167	ictus isquémico
#2	AnnotatorNotes T3	C0948008; Ischemic stroke; Disease or Syndrome
T4	PROC 189 262	Ensayo clínico fase II, multicéntrico, abierto, controlado y aleatorizado
T5	PROC 269 288	valorar la eficacia
#3	AnnotatorNotes T5	C1707887; Efficacy Study; Research Activity
T6	ANAT 322 358	células mononucleadas de médula ósea
T7	DISO 385 400	ictus isquémico
#4	AnnotatorNotes T7	C0948008; Ischemic stroke; Disease or Syndrome
T8	DISO 423 438	Ictus isquémico
#5	AnnotatorNotes T8	C0948008; Ischemic stroke; Disease or Syndrome
T9	PROC 537 570	Diagnóstico clínico y radiológico
T10	DISO 574 591	infarto isquémico
#6	AnnotatorNotes T10	C0333550; Anemic infarct; Pathologic Function
T11	ANAT 609 612	ACM
#7	AnnotatorNotes T11	C0149566; Structure of middle cerebral artery; Body Part, Organ, or Organ Component + C1269012; Entire middle cerebral artery; Body Part, Organ, or Organ Component
T12	DISO 697 705	síntomas
#8	AnnotatorNotes T12	C1457887; Symptoms; Sign or Symptom
T13	DISO 737 753	infarto cerebral
#9	AnnotatorNotes T13	C0007785; Cerebral Infarction; Disease or Syndrome | C0751955; Brain Infarction; Disease or Syndrome
T14	ANAT 773 776	ACM
#10	AnnotatorNotes T14	C0149566; Structure of middle cerebral artery; Body Part, Organ, or Organ Component + C1269012; Entire middle cerebral artery; Body Part, Organ, or Organ Component
T15	PROC 781 801	resonancia magnética
#11	AnnotatorNotes T15	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T16	PROC 802 828	angio resonancia magnética
T17	PROC 830 832	RM
#12	AnnotatorNotes T17	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T18	PROC 833 836	aRM
#13	AnnotatorNotes T18	C0243032; Magnetic Resonance Angiography; Diagnostic Procedure
T19	DISO 852 871	déficit neurológico
#14	AnnotatorNotes T19	C0521654; Neurologic Deficits; Finding
T20	DISO 961 978	Pérdida de fuerza
#15	AnnotatorNotes T20	C3714552; Weakness; Sign or Symptom
T21	DISO 1050 1056	afasia
#16	AnnotatorNotes T21	C0003537; Aphasia; Mental or Behavioral Dysfunction
T22	PROC 1338 1343	NIHSS
#17	AnnotatorNotes T22	C3472497; Assessment using National Institutes of Health stroke scale; Health Care Activity
T23	PROC 1020 1025	NIHSS
#18	AnnotatorNotes T23	C3472497; Assessment using National Institutes of Health stroke scale; Health Care Activity
T24	PROC 882 924	National Institutes of Health Stroke Scale
#19	AnnotatorNotes T24	C3472497; Assessment using National Institutes of Health stroke scale; Health Care Activity
T25	DISO 1173 1191	disección arterial
#20	AnnotatorNotes T25	C0002949; Aneurysm, Dissecting; Disease or Syndrome
T26	DISO 1197 1214	Ictus hemorrágico
#21	AnnotatorNotes T26	C0472369; Hemorrhagic cerebral infarction; Disease or Syndrome
T27	DISO 1217 1224	infarto
#22	AnnotatorNotes T27	C0021308; Infarction; Pathologic Function | C0007785; Cerebral Infarction; Disease or Syndrome | C0751955; Brain Infarction; Disease or Syndrome
T28	DISO 1229 1267	transformación hemorrágica sintomática
T29	DISO 1287 1302	infarto lacunar
#23	AnnotatorNotes T29	C0333559; Infarction, Lacunar; Disease or Syndrome
T30	PROC 1389 1400	tratamiento
#24	AnnotatorNotes T30	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T31	DISO 1415 1420	edema
#25	AnnotatorNotes T31	C0013604; Edema; Pathologic Function
T32	DISO 1425 1444	hemorragia cerebral
#26	AnnotatorNotes T32	C0553692; Brain hemorrhage; Pathologic Function | C2937358; Cerebral Hemorrhage; Pathologic Function
T33	DISO 1473 1514	infarto maligno de arteria cerebral media
#27	AnnotatorNotes T33	C0740392; Infarction, Middle Cerebral Artery; Disease or Syndrome
T34	ANAT 1492 1514	arteria cerebral media
#28	AnnotatorNotes T34	C0149566; Structure of middle cerebral artery; Body Part, Organ, or Organ Component + C1269012; Entire middle cerebral artery; Body Part, Organ, or Organ Component
T35	PROC 1641 1643	RM
#29	AnnotatorNotes T35	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T36	DISO 1663 1679	tumores malignos
#30	AnnotatorNotes T36	C0006826; Malignant Neoplasms; Neoplastic Process
T37	DISO 1689 1710	carcinoma basocelular
#31	AnnotatorNotes T37	C0007117; Basal cell carcinoma; Neoplastic Process
T38	DISO 1770 1775	ictus
#32	AnnotatorNotes T38	C0038454; Cerebrovascular accident; Disease or Syndrome
T39	DISO 1799 1831	Enfermedades neuro-degenerativas
T40	PROC 1534 1559	escala de coma de Glasgow
#33	AnnotatorNotes T40	C0278349; Glasgow coma testing and evaluation; Laboratory Procedure
T41	DISO 1838 1874	Insuficiencia cardíaca descompensada
T42	DISO 1922 1945	enfermedad hematológica
#34	AnnotatorNotes T42	C0018939; Hematological Disease; Disease or Syndrome
T43	ANAT 1988 1999	médula ósea
#35	AnnotatorNotes T43	C0005953; Bone Marrow; Tissue
T44	DISO 2006 2019	Coagulopatías
#36	AnnotatorNotes T44	C0005779; Blood Coagulation Disorders; Disease or Syndrome
T45	DISO 2026 2048	Insuficiencia hepática
#37	AnnotatorNotes T45	C0085605; Liver Failure; Disease or Syndrome | C1306571; Hepatic Insufficiency; Pathologic Function
T46	DISO 2055 2074	Insuficiencia renal
#38	AnnotatorNotes T46	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T47	DISO 2121 2147	Enfermedades concomitantes
#39	AnnotatorNotes T47	C0243087; concomitant disease; Pathologic Function
T48	PROC 2247 2268	método anticonceptivo
#40	AnnotatorNotes T48	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T49	PROC 2369 2383	ensayo clínico
#41	AnnotatorNotes T49	C0008976; Clinical Trials; Research Activity
T50	PROC 83 114	administración de células madre
T51	PROC 295 318	infusión intra arterial
#42	AnnotatorNotes T51	C0021439; Intra-Arterial Infusions; Therapeutic or Preventive Procedure
T52	PROC 710 733	Diagnóstico radiológico
T53	ANAT 745 753	cerebral
#43	AnnotatorNotes T53	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T54	PROC 1130 1149	examen angiográfico
T55	PROC 875 880	NIHSS
#44	AnnotatorNotes T55	C3472497; Assessment using National Institutes of Health stroke scale; Health Care Activity
T56	ANAT 1183 1191	arterial
#45	AnnotatorNotes T56	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T57	ANAT 1436 1444	cerebral
#46	AnnotatorNotes T57	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T58	DISO 1520 1527	Déficit
#47	AnnotatorNotes T58	C0162429; Malnutrition; Disease or Syndrome
T59	DISO 1544 1548	coma
#48	AnnotatorNotes T59	C0009421; Comatose; Disease or Syndrome
T60	ANAT 1699 1710	basocelular
#49	AnnotatorNotes T60	C0596155; Basal Cell; Cell
T61	ANAT 1852 1860	cardíaca
#50	AnnotatorNotes T61	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T62	PROC 1732 1759	escala de Rankin modificada
#51	AnnotatorNotes T62	C3888574; Modified Rankin score; Diagnostic Procedure
T63	PROC 1977 1999	punción de médula ósea
T64	ANAT 2040 2048	hepática
#52	AnnotatorNotes T64	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T65	ANAT 2069 2074	renal
#53	AnnotatorNotes T65	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T66	PROC 2085 2095	creatinina
#54	AnnotatorNotes T66	C0201975; Creatinine measurement; Laboratory Procedure
T67	Date 12 16	2013
T68	LIVB 126 134	paciente
#55	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T69	LIVB 138 147	pacientes
#56	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T70	Route 304 318	intra arterial
T71	LIVB 371 380	pacientes
#57	AnnotatorNotes T71	C0030705; Patients; Patient or Disabled Group
T72	LIVB 468 492	Pacientes de ambos sexos
#58	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group + C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T73	Age 514 532	entre 18 y 80 años
T74	Duration 624 632	24 horas
T75	Neg_cue 649 651	no
T76	Duration 652 665	más de 7 días
T77	Neg_cue 1026 1033	excepto
T78	Spec_cue 1161 1172	sospecha de
T79	LIVB 1273 1282	Pacientes
#59	AnnotatorNotes T79	C0030705; Patients; Patient or Disabled Group
T80	Duration 1365 1377	las 24 horas
T81	Spec_cue 1447 1458	sospecha de
T82	LIVB 1649 1658	Pacientes
#60	AnnotatorNotes T82	C0030705; Patients; Patient or Disabled Group
T83	Neg_cue 1681 1688	excepto
T85	LIVB 2161 2205	Mujeres embarazadas, en periodo de lactancia
#61	AnnotatorNotes T85	C0033011; Pregnant Women; Population Group + C4316174; Patients who are breastfeeding; Patient or Disabled Group
T86	Age 2212 2223	edad fértil
T87	PHYS 2196 2205	lactancia
#62	AnnotatorNotes T87	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T88	Neg_cue 2228 2230	no
T89	LIVB 2282 2291	Pacientes
#63	AnnotatorNotes T89	C0030705; Patients; Patient or Disabled Group
T90	Date 2302 2313	actualmente
T91	Duration 2398 2416	inferior a 3 meses
T84	PHYS 2169 2180	embarazadas
#64	AnnotatorNotes T84	C0032961; Pregnancy; Organism Function
A1	Assertion T76 Negated
A2	Assertion T21 Negated
A3	Assertion T25 Speculated
A4	Assertion T33 Speculated
A5	Assertion T37 Negated
A6	Assertion T48 Negated
A7	Assertion T54 Negated
A8	Assertion T35 Contraindicated
A9	Assertion T35 Negated
A10	Assertion T63 Contraindicated
A11	Status T49 History_of
#65	AnnotatorNotes T1	C1707887; Efficacy Study; Research Activity
#66	AnnotatorNotes T4	C0282460; Phase 2 Clinical Trials; Research Activity + C1096776; Multicenter Study; Research Activity + C1709323; Open Label Study; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity
#67	AnnotatorNotes T90	C0521116; Current (present time); Temporal Concept 
#68	AnnotatorNotes T70	C1561451; Intraarterial Route of Drug Administration; Functional Concept 
#69	AnnotatorNotes T6	C5235893; Bone Marrow-Derived Mononuclear Cells; Cell
#70	AnnotatorNotes T16	C0243032; Magnetic Resonance Angiography; Diagnostic Procedure
#71	AnnotatorNotes T39	C0524851; Neurodegenerative Disorders; Disease or Syndrome
#72	AnnotatorNotes T41	C0581377; Decompensated cardiac failure; Disease or Syndrome
T92	Quantifier_or_Qualifier 1057 1061	pura
A12	Assertion T92 Negated
A13	Assertion T54 Negated
R1	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T92	
T93	Neg_cue 1091 1102	Incapacidad
T94	Neg_cue 1585 1598	Imposibilidad
R2	Negation Arg1:T93 Arg2:T54	
R3	Negation Arg1:T94 Arg2:T35	
T95	Quantifier_or_Qualifier 2269 2275	eficaz
A14	Assertion T95 Negated
R4	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T95	
R5	Negation Arg1:T88 Arg2:T48	
R6	Negation Arg1:T88 Arg2:T95	
R7	Negation Arg1:T83 Arg2:T37	
#73	AnnotatorNotes T95	C1704419; Effective; Qualitative Concept
R8	Experiences Arg1:T68 Arg2:T50	
R9	Experiences Arg1:T69 Arg2:T50	
R10	Experiences Arg1:T68 Arg2:T3	
R11	Experiences Arg1:T69 Arg2:T3	
R12	Used_for Arg1:T6 Arg2:T51	
R13	Has_Route_or_Mode Arg1:T51 Arg2:T70	
R14	Experiences Arg1:T71 Arg2:T51	
R15	Experiences Arg1:T71 Arg2:T7	
T96	Quantifier_or_Qualifier 359 367	autóloga
#74	AnnotatorNotes T96	C0439859; Autologous (qualifier value); Qualitative Concept
R16	Has_Quantifier_or_Qualifier Arg1:T51 Arg2:T96	
R17	Has_Age Arg1:T72 Arg2:T73	
R18	Location_of Arg1:T11 Arg2:T10	
R19	After Arg1:T10 Arg2:T74	
R20	Negation Arg1:T75 Arg2:T76	
R21	Has_Duration_or_Interval Arg1:T10 Arg2:T76	
R22	After Arg1:T10 Arg2:T12	
R23	Causes Arg1:T10 Arg2:T12	
T97	CONC 636 642	inicio
#75	AnnotatorNotes T97	C0439659; Beginning; Temporal Concept
R24	Before Arg1:T97 Arg2:T74	
R25	Location_of Arg1:T53 Arg2:T13	
R26	Before Arg1:T15 Arg2:T52	
R27	Before Arg1:T16 Arg2:T52	
R28	Before Arg1:T17 Arg2:T52	
R29	Before Arg1:T18 Arg2:T52	
T98	Observation 756 776	permeabilidad de ACM
T99	Result_or_Value 929 955	más de 6 puntos y hasta 20
R38	Has_Result_or_Value Arg1:T24 Arg2:T99	
R39	Has_Result_or_Value Arg1:T55 Arg2:T99	
T100	Result_or_Value 982 999	al menos 2 puntos
R43	Has_Result_or_Value Arg1:T23 Arg2:T100	
R44	Negation Arg1:T77 Arg2:T21	
R45	Negation Arg1:T77 Arg2:T92	
#76	AnnotatorNotes T54	C0002978; angiogram; Diagnostic Procedure
R46	Speculation Arg1:T78 Arg2:T25	
R47	Location_of Arg1:T56 Arg2:T25	
R48	Overlap Arg1:T27 Arg2:T28	
R49	Experiences Arg1:T79 Arg2:T29	
T101	Result_or_Value 1347 1361	4 puntos o más
T102	Observation 1308 1321	Empeoramiento
#77	AnnotatorNotes T102	C1457868; Worse; Finding
R51	Has_Result_or_Value Arg1:T102 Arg2:T101	
R52	Overlap Arg1:T102 Arg2:T80	
R53	Before Arg1:T102 Arg2:T30	
R54	Causes Arg1:T31 Arg2:T102	
R55	Location_of Arg1:T57 Arg2:T32	
R56	Causes Arg1:T32 Arg2:T102	
R57	Speculation Arg1:T81 Arg2:T33	
R58	Causes Arg1:T33 Arg2:T102	
R59	Location_of Arg1:T34 Arg2:T33	
T103	Result_or_Value 1560 1579	inferior a 8 puntos
R62	Has_Result_or_Value Arg1:T40 Arg2:T103	
R63	Experiences Arg1:T82 Arg2:T36	
R64	Experiences Arg1:T82 Arg2:T37	
R65	Location_of Arg1:T60 Arg2:T37	
R66	Before Arg1:T62 Arg2:T38	
T104	Result_or_Value 1776 1793	mayor o igual a 2
R68	Location_of Arg1:T61 Arg2:T41	
T105	Quantifier_or_Qualifier 1877 1882	aguda
#78	AnnotatorNotes T105	C0439557; Acute phase; Temporal Concept
R69	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T105	
R70	Location_of Arg1:T43 Arg2:T63	
#79	AnnotatorNotes T63	C0005954; Bone marrow biopsy; Diagnostic Procedure (?)
R71	Location_of Arg1:T64 Arg2:T45	
R72	Location_of Arg1:T65 Arg2:T46	
T106	Result_or_Value 2096 2114	mayor de 2 mg / dl
R74	Has_Result_or_Value Arg1:T66 Arg2:T106	
T107	Quantifier_or_Qualifier 2075 2083	moderada
#80	AnnotatorNotes T107	C0205081; Moderate (severity modifier); Qualitative Concept
R75	Has_Quantifier_or_Qualifier Arg1:T46 Arg2:T107	
T108	Quantifier_or_Qualifier 2148 2154	graves
#81	AnnotatorNotes T108	C1547227; Severe - Severity of Illness Code; Intellectual Product
R76	Has_Quantifier_or_Qualifier Arg1:T47 Arg2:T108	
R77	Experiences Arg1:T85 Arg2:T84	
R78	Experiences Arg1:T85 Arg2:T87	
R79	Experiences Arg1:T85 Arg2:T48	
T109	Observation 2314 2326	participando
#82	AnnotatorNotes T109	C1278516; Patient participation status; Finding
R81	Overlap Arg1:T109 Arg2:T90	
T110	Observation 2335 2383	finalizado su participación en un ensayo clínico
A15	Status T110 History_of
#83	AnnotatorNotes T110	C2732579; Completion of clinical trial; Finding
R82	Has_Duration_or_Interval Arg1:T110 Arg2:T91	
R83	Has_Duration_or_Interval Arg1:T49 Arg2:T91	
R80	Has_Age Arg1:T85 Arg2:T86	
R30	Has_Result_or_Value Arg1:T62 Arg2:T104	
#84	AnnotatorNotes T52	C0043299; Diagnostic radiologic examination; Diagnostic Procedure
#85	AnnotatorNotes T92	C4724033; Pure; Qualitative Concept
A16	Experiencer T68 Patient
A17	Experiencer T69 Patient
A18	Experiencer T71 Patient
A19	Experiencer T72 Patient
A20	Experiencer T79 Patient
A21	Experiencer T82 Patient
A22	Experiencer T85 Patient
A23	Experiencer T89 Patient
